½ÃÀ庸°í¼­
»óǰÄÚµå
1610295

¼¼°èÀÇ ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ ½ÃÀå : Á¦Ç° À¯Çü, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Positron Emission Tomography Market by Product Type (Full Ring PET Scanners, Partial Ring PET Scanners), Application (Cardiology, Neurology, Oncology), End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 189 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ ½ÃÀåÀº 2023³â 26¾ï 1,000¸¸ ´Þ·¯, 2024³â 27¾ï 4,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç CAGR 6.22%·Î ¼ºÀåÇØ 2030³â 39¾ï 8,000¸¸ ´Þ·¯°¡ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ(PET)Àº ¾Ï, ½Å°æÁúȯ, ½ÉÇ÷°üÁúȯ µî ´Ù¾çÇÑ ÁúȯÀÇ Áø´Ü°ú °ü¸®¿¡ ÇʼöÀûÀÎ ºñħ½ÀÀû À̹Ì¡ ±â¼úÀÔ´Ï´Ù. ÀÚ¼¼ÇÑ ³»¿ëÀ» Á¦°øÇÏ´Â CT ¹× MR I¿Í °°Àº ´Ù¸¥ ¿µ»ó ¾ç½Ä°ú´Â ´Ù¸¥ ´ë»ç ¹× ±â´É Á¤º¸¸¦ Á¦°øÇÏ´Â ´É·ÂÀ¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. ³ú Àå¾ÖÀÇ ¿¬±¸¿¡ µµ¿òÀÌ µÇ´Â ½Å°æÇп¡ °ÉÃÄ ÀÖ½À´Ï´Ù. ±× ÃÖÁ¾ ¿ëµµ´Â º´¿ø, ¿¬±¸ ±â°ü, Áø´Ü¼¾ÅÍ¿¡±îÁö ¹ÌĨ´Ï´Ù. °Ë»ç½Ã°£ ´ÜÃàÀ» ½ÇÇöÇÏ´Â ±â¼úÀÇ Áøº¸ÀÔ´Ï´Ù. ³ëÀÎ Àα¸ Áõ°¡°¡ ¼ö¿ä¸¦ ÇÑÃþ ´õ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. PET/MRI¿Í °°Àº ÇÏÀ̺긮µå À̹Ì¡ ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ´Â Á¾ÇÕÀûÀÎ Áø´Ü ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â ¹Ì°³Ã´ °¡´É¼ºÀ» º¸¿©ÁÝ´Ï´Ù. ¶ÇÇÑ ¹æ»ç¼º¹°ÁúÀ» ´Ù·ê ¶§ÀÇ ¹°·ùÀÇ º¹À⼺µµ À庮ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÈÞ´ë¿ë PET ½Ã½ºÅÛÀÇ ¿¬±¸´Â ¿ø°ÝÁö¿¡¼­ÀÇ Á¢±Ù¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ÅõÀÚ ±â¾÷Àº ÀÇ·á±â°ü°úÀÇ Çù·Â°ü°è¸¦ Ȱ¿ëÇÏ°í ³ëµ¿·ÂÀ» È®º¸Çϱâ À§ÇÑ Æ®·¹ÀÌ´× ÇÁ·Î±×·¥¿¡ ÅõÀÚÇÔÀ¸·Î½á Áö¼ÓÀûÀÎ ½ÃÀå È®´ë¸¦ ¾à¼ÓÇÏ´Â ±â¼úÀû¡¤Àα¸Àû ½ÃÇÁÆ®¸¦ Ȱ¿ëÇÒ ¼ö Àִ üÁ¦¸¦ Á¤µ·ÇؾßÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 26¾ï 1,000¸¸ ´Þ·¯
ÃßÁ¤³â(2024) 27¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 39¾ï 8,000¸¸ ´Þ·¯
CAGR(%) 6.22%

½ÃÀå ¿ªÇÐ: ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿Àû ÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖ¾î, ¼ÒºñÀÚ Çൿ°ú ±×°Í Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ÀÇ·á¿ë È­»ó 󸮿¡ ´ëÇÑ ¿ä±¸ Áõ°¡
    • ÇコÄɾî ÀÎÇÁ¶ó Á¤ºñ¸¦ À§ÇÑ Á¤ºÎ ÅõÀÚ Áõ°¡
    • ¼¼°èÀÇ ÀÓ»ó½ÃÇè¼ö Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ ÀýÂ÷ÀÇ ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µÀÇ Áøº¸
    • ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µÀÇ ¿ëµµ¿Í ¹üÀ§¸¦ È®´ëÇϱâ À§ÇÑ Áö¼ÓÀûÀÎ Á¶»ç
  • ½ÃÀåÀÇ °úÁ¦
    • ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µÀÇ »ç¿ë¼ºÀÇ ÇѰè

Porter's Five Force : ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Force Framework´Â ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÇÇÇÒ ¼ö ÀÖÀ¸¸ç ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸Àå ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÏ¸é ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ º¥´õÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀå ÁýÁß, ´ÜÆíÈ­ ¹× ÅëÇÕ µ¿ÇâÀ» ¸íÈ®È÷ÇÏ°í º¥´õ´Â °æÀïÀÌ Ä¡¿­ ÇØÁü¿¡ µû¶ó ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÕ´Ï´Ù. Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Á¤º¸¸¦ ±â¹ÝÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÐ·ùÇϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·«ºÐ¼®°ú Ãßõ : ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸³´Ï´Ù.

¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ ¹æ¹ýÀ» »ç¿ëÇÏ¸é °æÀï ±¸µµ¿¡¼­ ¾î·Á¿òÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϰí, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ÀÇ·á ¿µ»ó Áø´ÜÀÇ Çʿ伺 Áõ°¡
      • °æÁ¦ÀÇ °Ç°­ °ü¸® ÀÎÇÁ¶ó °³¼±À» À§ÇÑ Á¤ºÎ ÅõÀÚ Áõ°¡
      • ¼¼°è¿¡¼­ Áõ°¡ÇÏ´Â ÀÓ»ó½ÃÇèÀÇ ¼ö
    • ¾ïÁ¦¿äÀÎ
      • ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ ÀýÂ÷ÀÇ ºñ¿ëÀÌ ³ô´Ù
    • ±âȸ
      • ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µÀÇ Áøº¸
      • ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µÀÇ »ç¿ë°ú ¹üÀ§¸¦ È®´ëÇϱâ À§ÇÑ Áö¼ÓÀûÀÎ Á¶»ç
    • °úÁ¦
      • ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µÀÇ »ç¿ë¼º Á¦ÇÑ
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ ½ÃÀå : Á¦Ç° À¯Çüº°

  • Ç® ¸µ PET ½ºÄ³³Ê
  • ºÎºÐ ¸µ PET ½ºÄ³³Ê

Á¦7Àå ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ ½ÃÀå : ¿ëµµº°

  • ½ÉÀ庴ÇÐ
  • ½Å°æÇÐ
  • Á¾¾çÇÐ

Á¦8Àå ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • Áø´Ü¼¾ÅÍ
  • º´¿ø

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Agfa group
  • Cerveau Technologies, Inc.
  • CMR Naviscan Corporation
  • GE Healthcare
  • Hitachi, Ltd.
  • Koninklijke Philips NV
  • MedX Holdings Inc.
  • Modus Medical Devices Inc.
  • Neusoft Corporation
  • Radiology Oncology Systems, Inc.
  • Segami Corporation
  • Siemens Healthcare Private Limited
  • Spectrum Dynamics Ltd.
  • Toshiba Corporation
  • Yangzhou Kindsway Biotech Co., Ltd.
JHS 24.12.20

The Positron Emission Tomography Market was valued at USD 2.61 billion in 2023, expected to reach USD 2.74 billion in 2024, and is projected to grow at a CAGR of 6.22%, to USD 3.98 billion by 2030.

Positron Emission Tomography (PET) is a non-invasive imaging technology crucial in diagnosing and managing various diseases, including cancer, neurological disorders, and cardiovascular conditions. The necessity for PET arises from its ability to provide metabolic and functional information, distinguishing it from other imaging modalities like CT and MRI, which primarily offer anatomical detail. The application of PET spans across oncology, with a significant role in assessing tumor progression and treatment efficacy, as well as neurology, where it aids in studying brain disorders like Alzheimer's disease. Its end-use extends to hospitals, research institutions, and diagnostic centers. Market growth is driven by advancements in radiotracers, increasing prevalence of chronic diseases, and technological advancements that enhance image quality and reduce examination times. The growing geriatric population further fuels demand. Potential opportunities lie in integrating artificial intelligence to improve diagnostic accuracy and operational efficiency, expanding into emerging markets where access to healthcare is burgeoning. Investment in hybrid imaging technologies, such as PET/MRI, represents untapped potential to provide comprehensive diagnostic solutions. However, limitations include high costs, regulatory challenges, and a shortage of skilled professionals. The logistical complexities of handling radioactive substances also pose barriers. Innovation can focus on developing cost-effective, targeted tracers and enhancing scanner sensitivity to lower radiation doses. Additionally, research into portable PET systems could enhance accessibility in remote regions. The market is characterized by rapid technological advancements and a push towards personalized medicine, with key players investing in R&D to maintain a competitive edge. Businesses should capitalize on collaborations with healthcare institutions and invest in training programs to ensure workforce readiness, positioning themselves to leverage technological and demographic shifts that promise sustained market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 2.61 billion
Estimated Year [2024] USD 2.74 billion
Forecast Year [2030] USD 3.98 billion
CAGR (%) 6.22%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Positron Emission Tomography Market

The Positron Emission Tomography Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing need for medical imaging
    • Rising government investments to improve healthcare infrastructure in economies
    • Growing number of clinical trials worldwide
  • Market Restraints
    • High cost of positron emission tomography procedure
  • Market Opportunities
    • Advancements in positron emission tomography
    • Ongoing research to expand use and scope of positron emission tomography
  • Market Challenges
    • Usability limitations of positron emission tomography

Porter's Five Forces: A Strategic Tool for Navigating the Positron Emission Tomography Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Positron Emission Tomography Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Positron Emission Tomography Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Positron Emission Tomography Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Positron Emission Tomography Market

A detailed market share analysis in the Positron Emission Tomography Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Positron Emission Tomography Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Positron Emission Tomography Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Positron Emission Tomography Market

A strategic analysis of the Positron Emission Tomography Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Positron Emission Tomography Market, highlighting leading vendors and their innovative profiles. These include Agfa group, Cerveau Technologies, Inc., CMR Naviscan Corporation, GE Healthcare, Hitachi, Ltd., Koninklijke Philips N.V., MedX Holdings Inc., Modus Medical Devices Inc., Neusoft Corporation, Radiology Oncology Systems, Inc., Segami Corporation, Siemens Healthcare Private Limited, Spectrum Dynamics Ltd., Toshiba Corporation, and Yangzhou Kindsway Biotech Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Positron Emission Tomography Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Full Ring PET Scanners and Partial Ring PET Scanners.
  • Based on Application, market is studied across Cardiology, Neurology, and Oncology.
  • Based on End-User, market is studied across Diagnostic Centers and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing need for medical imaging
      • 5.1.1.2. Rising government investments to improve healthcare infrastructure in economies
      • 5.1.1.3. Growing number of clinical trials worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of positron emission tomography procedure
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in positron emission tomography
      • 5.1.3.2. Ongoing research to expand use and scope of positron emission tomography
    • 5.1.4. Challenges
      • 5.1.4.1. Usability limitations of positron emission tomography
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Positron Emission Tomography Market, by Product Type

  • 6.1. Introduction
  • 6.2. Full Ring PET Scanners
  • 6.3. Partial Ring PET Scanners

7. Positron Emission Tomography Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiology
  • 7.3. Neurology
  • 7.4. Oncology

8. Positron Emission Tomography Market, by End-User

  • 8.1. Introduction
  • 8.2. Diagnostic Centers
  • 8.3. Hospitals

9. Americas Positron Emission Tomography Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Positron Emission Tomography Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Positron Emission Tomography Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agfa group
  • 2. Cerveau Technologies, Inc.
  • 3. CMR Naviscan Corporation
  • 4. GE Healthcare
  • 5. Hitachi, Ltd.
  • 6. Koninklijke Philips N.V.
  • 7. MedX Holdings Inc.
  • 8. Modus Medical Devices Inc.
  • 9. Neusoft Corporation
  • 10. Radiology Oncology Systems, Inc.
  • 11. Segami Corporation
  • 12. Siemens Healthcare Private Limited
  • 13. Spectrum Dynamics Ltd.
  • 14. Toshiba Corporation
  • 15. Yangzhou Kindsway Biotech Co., Ltd.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦